Sheldon L. Koenig
Also at Esperion Therapeutics Inc
About
Sheldon L. Koenig has built an extensive career in the pharmaceutical industry with over 25 years of experience, including leadership roles at Merck & Co., Sanofi, and Portola Pharmaceuticals.
At Esperion Therapeutics, he has been instrumental in steering strategic initiatives focused on revenue growth, operating profitability, and portfolio expansion. His efforts have led to the development of innovative therapies and strategic product combinations aimed at addressing preventative cardiovascular care.
His strong academic foundation, underscored by advanced degrees, has enabled him to navigate complex global markets and drive significant advancements in the industry. This blend of strategic vision and operational expertise continues to shape his impactful contributions to the success of Esperion Therapeutics.
$ESPR Performance Under Sheldon L. Koenig
Past Roles
Fixed Compensation
Performance Compensation
Non-equity Incentive Plan Compensation
- Overall Achievement: 115% of target.
- Target Award Opportunity: 65% of base salary (i.e., 65% of $725,000 = $471,250).
- Actual Bonus Payment: $541,938 (calculated as 115% of target bonus).
- Evaluation Period: Performance evaluated during 2023 with final payout in December 2023.
- Vesting Schedule & Grant Date: Not applicable as the compensation was a cash bonus without equity vesting.